Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Spain; Centro de Investigaciones Biomédicas en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.
Gastroenterology and Hepatology, Hospital del Mar, Barcelona, Spain.
J Hepatol. 2019 Nov;71(5):942-950. doi: 10.1016/j.jhep.2019.07.007. Epub 2019 Jul 19.
BACKGROUND & AIMS: Surgery in cirrhosis is associated with a high morbidity and mortality. Retrospectively reported prognostic factors include emergency procedures, liver function (MELD/Child-Pugh scores) and portal hypertension (assessed by indirect markers). This study assessed the prognostic role of hepatic venous pressure gradient (HVPG) and other variables in elective extrahepatic surgery in patients with cirrhosis.
A total of 140 patients with cirrhosis (Child-Pugh A/B/C: 59/37/4%), who were due to have elective extrahepatic surgery (121 abdominal; 9 cardiovascular/thoracic; 10 orthopedic and others), were prospectively included in 4 centers (2002-2011). Hepatic and systemic hemodynamics (HVPG, indocyanine green clearance, pulmonary artery catheterization) were assessed prior to surgery, and clinical and laboratory data were collected. Patients were followed-up for 1 year and mortality, transplantation, morbidity and post-surgical decompensation were studied.
Ninety-day and 1-year mortality rates were 8% and 17%, respectively. Variables independently associated with 1-year mortality were ASA class (American Society of Anesthesiologists), high-risk surgery (defined as open abdominal and cardiovascular/thoracic) and HVPG. These variables closely predicted 90-, 180- and 365-day mortality (C-statistic >0.8). HVPG values >16 mmHg were independently associated with mortality and values ≥20 mmHg identified a subgroup at very high risk of death (44%). Twenty-four patients presented persistent or de novo decompensation at 3 months. Low body mass index, Child-Pugh class and high-risk surgery were associated with death or decompensation. No patient with HVPG <10 mmHg or indocyanine green clearance >0.63 developed decompensation.
ASA class, HVPG and high-risk surgery were prognostic factors of 1-year mortality in cirrhotic patients undergoing elective extrahepatic surgery. HVPG values >16 mmHg, especially ≥20 mmHg, were associated with a high risk of post-surgical mortality.
The hepatic venous pressure gradient is associated with outcomes in patients with cirrhosis undergoing elective extrahepatic surgery. It enables a better stratification of risk in these patients and provides the foundations for potential interventions to improve post-surgical outcomes.
肝硬化患者的手术相关发病率和死亡率较高。回顾性报告的预后因素包括紧急手术、肝功能(MELD/Child-Pugh 评分)和门脉高压(通过间接标志物评估)。本研究评估了肝静脉压力梯度(HVPG)和其他变量在肝硬化患者择期行肝外手术中的预后作用。
共有 140 例肝硬化患者(Child-Pugh A/B/C:59/37/4%),因择期行肝外手术(121 例腹部手术;9 例心血管/胸外科手术;10 例骨科及其他手术)而被前瞻性纳入 4 家中心(2002-2011 年)。手术前评估肝和全身血液动力学(HVPG、吲哚菁绿清除率、肺动脉导管),并收集临床和实验室数据。对患者进行 1 年随访,研究死亡率、移植率、发病率和术后失代偿情况。
90 天和 1 年死亡率分别为 8%和 17%。与 1 年死亡率独立相关的变量是美国麻醉医师协会(ASA)分级、高危手术(定义为开放性腹部和心血管/胸外科手术)和 HVPG。这些变量密切预测了 90 天、180 天和 365 天的死亡率(C 统计量>0.8)。HVPG 值>16mmHg 与死亡率独立相关,HVPG 值≥20mmHg 提示死亡风险极高(44%)。3 个月时有 24 例患者出现持续或新发失代偿。低体重指数、Child-Pugh 分级和高危手术与死亡或失代偿相关。无 HVPG<10mmHg 或吲哚菁绿清除率>0.63 的患者发生失代偿。
ASA 分级、HVPG 和高危手术是肝硬化患者行择期肝外手术 1 年死亡率的预后因素。HVPG 值>16mmHg,尤其是≥20mmHg,与术后死亡率高相关。
说明:本译文尽量贴近原文,但由于语言习惯不同,部分内容可能无法完全对应。